Metastatic gastrointestinal stromal tumor with an Exon 11 c-Kit mutation responding to the tyrosine kinase inhibitor imatinib

被引:4
作者
Cho, H
Kobayashi, O
Tsuburaya, A
Sugiyama, Y
Sairenji, M
Motohashi, H
Yoshida, T
Miyagi, Y
Imada, T
机构
[1] Yokohama City Univ, Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Kanagawa 232, Japan
[2] Yokohama City Univ, Kanagawa Canc Ctr, Div Pathol, Lab Mol Diagnost, Yokohama, Kanagawa 232, Japan
[3] Yokohama City Univ, Med Ctr, Gastroenterol Ctr, Yokohama, Kanagawa 232, Japan
关键词
gastrointestinal stromal tumor; imatinib; C- kit mutation;
D O I
10.1159/000076756
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:74 / 77
页数:4
相关论文
共 50 条
[21]   Gastrointestinal stromal tumours and their response to treatment with the tyrosine kinase inhibitor imatinib [J].
Mechtersheimer, G ;
Egerer, G ;
Hensel, M ;
Rieker, RJ ;
Libicher, M ;
Lehnert, T ;
Penzel, R .
VIRCHOWS ARCHIV, 2004, 444 (02) :108-118
[22]   Secondary c-kit Mutation in a Recurrent Gastrointestinal Stromal Tumor Under Long-Term Treatment with Imatinib Mesylate: Report of a Case [J].
Tohru Utsunomiya ;
Masahiro Okamoto ;
Shuya Yano ;
Toshihumi Kameyama ;
Ayumi Matsuyama ;
Sosei Kuma ;
Manabu Yamamoto ;
Megumu Fujiwara ;
Teruyoshi Ishida .
Surgery Today, 2008, 38 :65-67
[23]   Secondary c-kit mutation in a recurrent gastrointestinal stromal tumor under long-term treatment with imatinib mesylate:: Report of a case [J].
Utsunomiya, Tohru ;
Okamoto, Masahiro ;
Yano, Shuya ;
Kameyama, Toshihumi ;
Matsuyama, Ayumi ;
Kuma, Sosei ;
Yamamoto, Manabu ;
Fujiwara, Megumu ;
Ishida, Teruyoshi .
SURGERY TODAY, 2008, 38 (01) :65-67
[24]   c-Kit mutation-positive advanced thymic carcinoma successfully treated as a mediastinal gastrointestinal stromal tumor: A case report [J].
Hirai, Fumihiko ;
Edagawa, Makoto ;
Shimamatsu, Shinichiro ;
Toyozawa, Ryo ;
Toyokawa, Gouji ;
Nosaki, Kaname ;
Yamaguchi, Masafumi ;
Seto, Takashi ;
Twakenoyama, Mitsuhiro ;
Ichinose, Yukito .
MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (04) :527-529
[25]   The clinicopathologic observation, c-KIT gene mutation and clonal status of gastrointestinal stromal tumor in the sacrum [J].
Li Gong ;
Yan-Hong Li ;
Hua-Dong Zhao ;
Jian-Ye Zhao ;
Wei Zhang .
BMC Gastroenterology, 9
[26]   C-KIT and PDGFRA Zygosity in Gastrointestinal Stromal Tumors: Correlation With Tumor Site, Tumor Size, Exon, and CD117 Immunohistochemistry [J].
Wallander, Michelle L. ;
Willmore-Payne, Carlynn ;
Layfield, Lester J. .
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2011, 19 (01) :21-27
[27]   Tyrosine Kinase Inhibitors for Gastrointestinal Stromal Tumor After Imatinib Resistance [J].
Xiao, Xian-Hao ;
Zhang, Qian-Shi ;
Hu, Ji-Yuan ;
Zhang, Yin-Xu ;
Song, He .
PHARMACEUTICS, 2025, 17 (07)
[28]   Molecular mechanism of D816X mutation-induced c-Kit activation and -mediated inhibitor resistance in gastrointestinal stromal tumor [J].
Jiang, Haohai ;
Shao, Weiwei ;
Wang, Yuanjin ;
Xu, Ronghui ;
Zhou, Linsen ;
Mu, Xiangming .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2018, 84 :189-196
[29]   Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era [J].
Turley, Ryan S. ;
Peng, Peter D. ;
Reddy, Srinevas K. ;
Barbas, Andrew S. ;
Geller, David A. ;
Marsh, J. Wallis ;
Tsung, Allan ;
Pawlik, Timothy M. ;
Clary, Bryan M. .
CANCER, 2012, 118 (14) :3571-3578
[30]   C-KIT mutations were closely associated with the response to Imatinib in Chinese advanced gastrointestinal stromal tumor patients [J].
Gao, Jing ;
Dang, Yunzhi ;
Sun, Naiping ;
Li, Jian ;
Shen, Lin .
MEDICAL ONCOLOGY, 2012, 29 (05) :3039-3045